|
|
 Previous Article | Table of Contents | Next Article 
Disparate Affinities of Antifolates for Folylpolyglutamate Synthetase From Human Leukemia Cells
Giuseppe S.A. Longo,
Richard Gorlick,
William P. Tong,
Emine Ercikan, and
Joseph R. Bertino
From the Departments of Molecular Pharmacology and Therapeutics and Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY.
Previous work showed that acute myelocytic leukemia blasts accumulate less long chain polyglutamates of methotrexate (MTX) than acute lymphocytic leukemia blasts when incubated with this radiolabeled antifolate. This difference likely explains the increased sensitivity of lymphoid leukemias to short-term exposure of MTX as compared with myeloid leukemias. In this study, we examined the basis for differences between long chain MTX polyglutamate accumulation between different leukemia cell types using both leukemia cell lines and blasts freshly isolated from blood of leukemic patients. The major difference found between leukemia cells that accumulate long chain polyglutamates and those that do not were differences in Km values for the enzyme folylpolyglutamate synthetase. Km values did not change with partial purification of this enzyme, indicating that interfering substances in crude lysates were not responsible for this difference. We postulate that there may be differences in the properties of this enzyme related to tissue specific expression. In contrast to MTX, both Tomudex (Zeneca Pharmaceuticals, Wilmington, DE) and 1843U89, potent inhibitors of thymidylate synthetase, have low Kms for folylpolyglutamate synthetase, and polyglutamate forms of these inhibitors are accumulated to the same degree in both myeloid and lymphoid acute leukemia cells, paralleling the equivalent cytotoxicity found between myeloid and lymphoid leukemia cell lines. Based on these results, we believe a clinical trial of Tomudex in patients with acute myeloid leukemia is warranted.
Blood, Vol. 90 No. 3 (August 1), 1997:
pp. 1241-1245
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
P. D. Cole, R. A. Drachtman, A. K. Smith, S. Cate, R. A. Larson, D. S. Hawkins, J. Holcenberg, K. Kelly, and B. A. Kamen
Phase II Trial of Oral Aminopterin for Adults and Children with Refractory Acute Leukemia
Clin. Cancer Res.,
November 15, 2005;
11(22):
8089 - 8096.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Robien
Folate During Antifolate Chemotherapy: What We Know... and Do Not Know
Nutr Clin Pract,
August 1, 2005;
20(4):
411 - 422.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. M. Horton, S. M. Blaney, A.-M. Langevin, J. Kuhn, B. Kamen, S. L. Berg, M. Bernstein, and S. Weitman
Phase I Trial and Pharmacokinetic Study of Raltitrexed in Children with Recurrent or Refractory Leukemia: A Pediatric Oncology Group Study
Clin. Cancer Res.,
March 1, 2005;
11(5):
1884 - 1889.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Panetta, A. Wall, C.-H. Pui, M. V. Relling, and W. E. Evans
Methotrexate Intracellular Disposition in Acute Lymphoblastic Leukemia: A Mathematical Model of {gamma}-Glutamyl Hydrolase Activity
Clin. Cancer Res.,
July 1, 2002;
8(7):
2423 - 2429.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. T. Veuger, M. H. M. Heemskerk, M. W. Honders, R. Willemze, and R. M. Y. Barge
Functional role of alternatively spliced deoxycytidine kinase in sensitivity to cytarabine of acute myeloid leukemic cells
Blood,
February 15, 2002;
99(4):
1373 - 1380.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. McGuire, C. A. Russell, and M. Balinska
Human Cytosolic and Mitochondrial Folylpolyglutamate Synthetase Are Electrophoretically Distinct. EXPRESSION IN ANTIFOLATE-SENSITIVE AND -RESISTANT HUMAN CELL LINES
J. Biol. Chem.,
April 21, 2000;
275(17):
13012 - 13016.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. B. Turner, J. L. Andreassi II, J. Ferguson, S. Titus, A. Tse, S. M. Taylor, and R. G. Moran
Tissue-specific Expression of Functional Isoforms of Mouse Folylpoly-{{gamma}}-glutamate Synthetase: A Basis for Targeting Folate Antimetabolites
Cancer Res.,
December 1, 1999;
59(24):
6074 - 6079.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. G. Rots, R. Pieters, G. J. Peters, C. H. van Zantwijk, R. Mauritz, P. Noordhuis, J. C. Willey, K. Hahlen, U. Creutzig, G. Janka-Schaub, et al.
Circumvention of Methotrexate Resistance in Childhood Leukemia Subtypes by Rationally Designed Antifolates
Blood,
November 1, 1999;
94(9):
3121 - 3128.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. F. Skibola, M. T. Smith, E. Kane, E. Roman, S. Rollinson, R. A. Cartwright, and G. Morgan
Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults
PNAS,
October 26, 1999;
96(22):
12810 - 12815.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. G. Rots, R. Pieters, G. J. Peters, P. Noordhuis, C. H. van Zantwijk, G. J.L. Kaspers, K. Hahlen, U. Creutzig, A. J.P. Veerman, and G. Jansen
Role of Folylpolyglutamate Synthetase and Folylpolyglutamate Hydrolase in Methotrexate Accumulation and Polyglutamylation in Childhood Leukemia
Blood,
March 1, 1999;
93(5):
1677 - 1683.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. B. Turner, S. M. Taylor, and R. G. Moran
Expression Patterns of the Multiple Transcripts from the Folylpolyglutamate Synthetase Gene in Human Leukemias and Normal Differentiated Tissues
J. Biol. Chem.,
November 10, 2000;
275(46):
35960 - 35968.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
